or
forgot password

    • cancer clinical trials in fairfax, VA

    • A Trial of Thymalfasin in Adult Patients With Hepatocellular Carcinoma
    Metropolitan Research
    Fairfax, Virginia
    Carcinoma, Hepatocellular
    VELCADE® (Bortezomib) With Rituximab in Subjects With Relapsed or Refractory Indolent B-Cell Lymphoma
    FNVHO - US Oncology
    Fairfax, Virginia 20031
    B-Cell Lymphoma, Follicular Lymphoma, Marginal Lymphoma
    A Phase III Study of the Efficacy of Taxotere/Aptosyn Versus Taxotere/Placebo in Non-Small Cell Lung Cancer Patients
    Fairfax Northern Virginia Hematology-Oncology, PC
    Fairfax, Virginia 22031
    Non-Small Cell Lung Cancer
    Gemcitabine/Oxaliplatin (GEMOX) vs Carboplatin/Paclitaxel (CP) in Non-Small Cell Lung Cancer (NSCLC)
    Fairfax Northern Virginia Hematology Oncology, PC
    Fairfax, Virginia 22031
    Carcinoma, Non-Small-Cell Lung
    Study of Talabostat + Docetaxel Versus Docetaxel in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy
    Annandale-Fairfax Virginia Hematology Oncology, PC
    Fairfax, Virginia 22031
    Carcinoma, Non-Small Cell Lung
    A Phase II Study of E7389 in Patients With Breast Cancer, Previously Treated With Anthracycline, Taxane and Capecitabine
    Fairfax Northern VA Hematology Oncology PC
    Fairfax, Virginia 22031
    Breast Cancer
    Trial of Outpatient Immunotherapy With Rituximab and Aldesleukin (IL-2) vs. Rituximab Alone for Non-Hodgkin's Lymphoma
    Fairfax Northern VA Hem-Onc PC
    Fairfax, Virginia 22031
    Non-Hodgkin's Lymphoma
    Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy
    Fairfax Northern Virginia Hematology / Oncology, PC
    Fairfax, Virginia 22031
    Carcinoma, Non-Small-Cell Lung, Lung Cancer, Neoplasms, Lung, Neoplasms, Pulmonary
    Doxil & Carboplatin Plus HER2+ in Metastatic Breast Cancer
    Fairfax Northern VA Hem-Onc PC
    Fairfax, Virginia 22031
    Metastatic Breast Cancer
    Safety and Efficacy Study for the Prevention of Nausea and Vomiting in Multiple Myeloma Patients Receiving Stem Cell Transplantation.
    Fairfax-Northern Virginia Hematology-Oncology PC
    Fairfax, Virginia 22031
    Multiple Myeloma
    Phase 2 Study of VX-950, Pegasys®, and Copegus® in Hepatitis C
    Metropolitan Research
    Fairfax, Virginia
    Chronic Hepatitis C
    AMR PH GL 2007 CL001 Phase 3 Trial in Patients With Small Cell Lung Cancer After Failure of First-Line Chemotherapy
    Fairfax Northern Virginia Hematology/Oncology
    Fairfax, Virginia 22031
    Small Cell Lung Cancer
    A Study of Mapatumumab in Combination With Paclitaxel and Carboplatin in Subjects With Non-small Cell Lung Cancer
    Fairfax-Northern Virginia Hematology Oncology, PC
    Fairfax, Virginia 22031
    Non Small Cell Lung Cancer
    Study to Evaluate Erlotinib With or Without SNDX-275 in the Treatment of Patients With Advanced NSCLC
    Fairfax Northern Virginia Hematology-Oncology
    Fairfax, Virginia
    Non-Small-Cell Lung Carcinoma, Carcinoma, Non-Small Cell Lung
    ASA404 or Placebo in Combination With Paclitaxel and Carboplatin as First-Line Treatment for Stage IIIb/IV Non-Small Cell Lung Cancer
    Medical Oncology & Hematology Associates of Northern Virginia
    Fairfax, Virginia 22031
    Non-Small Cell Lung Cancer
    Rheumatological Evaluation of Anastrozole and Letrozole as Adjuvant Treatment in Post-menopausal Women With Breast Cancer
    Medical Oncology & Hematology Associates of Northern Virginia
    Fairfax, Virginia 22031
    Breast Cancer
    Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Crohn's Disease
    Gastroenterology Associates of Northern Virginia
    Fairfax, Virginia 22031
    Crohn's Disease
    Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Ulcerative Colitis
    Gastroenterology Associates of Northern Virginia
    Fairfax, Virginia 22031
    Ulcerative Colitis
    New Individualized Therapy Trial for Metastatic Colorectal Cancer
    Virginia Cancer Specialists, PC
    Fairfax, Virginia 22031
    Colorectal Neoplasm, Colorectal Cancer
    Study of Bendamustine Combined With Bortezomib for Patients With Relapsed/Refractory Multiple Myeloma
    Fairfax Northern Virginia Hematology Oncology
    Fairfax, Virginia
    Multiple Myeloma
    Safety and Efficacy of TKI258 in FGFR1 Amplified and Non-amplified Metastatic HER2 Negative Breast Cancer
    Fairfax Northern Virginia Hematology Oncology Fairfax NVH
    Fairfax, Virginia 22031
    Metastatic Breast Cancer
    Intravenous BI 6727 (Volasertib) in 2nd Line Treatment of Urothelial Cancer
    1230.2.44 Boehringer Ingelheim Investigational Site
    Fairfax, Virginia
    Neoplasms
    Pilot Study Using Molecular Profiling to Find Potential Targets and Select Treatments for Patients With Metastatic Breast Cancer.
    Fairfax North Virginia Hematology Oncology
    Fairfax, Virginia 22031
    Metastatic Breast Cancer
    LDK378 Versus Chemotherapy in ALK Rearranged (ALK Positive) Patients Previously Treated With Chemotherapy (Platinum Doublet) and Crizotinib
    Fairfax Northern Virginia Hematology Oncology SC Virginia Cancer Specialists
    Fairfax, Virginia 22031
    Non-Small Cell Lung Cancer